J. Alejo

发表

General and Acute Care Surgical Procedures in Patients with Left Ventricular Assist Devices

W. Baumgartner, elliot k fishman, D. Efron, 2014, World Journal of Surgery.

Experiences Obtaining Insurance After Live Kidney Donation

D. Segev, R. Montgomery, N. Deshpande, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Survival Benefit of Primary Deceased Donor Transplantation With High‐KDPI Kidneys

D. Segev, E. Chow, A. Massie, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

PASC in Solid Organ Transplant Recipients With Self-reported SARS-CoV-2 Infection

T. Vannorsdall, D. Segev, A. Massie, 2022, Transplantation.

Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External Validation

A. Gaber, D. Segev, D. Warren, 2022, Transplantation.

Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation

D. Segev, R. Montgomery, A. Massie, 2016, Transplantation.

Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases

Ami A. Shah, J. Albayda, D. Segev, 2022, The Lancet Rheumatology.

Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series

J. Albayda, D. Segev, L. Christopher‐Stine, 2022, Rheumatology.

Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19.

M. Makary, D. Segev, A. Massie, 2022, JAMA.

Recipient age and outcomes following simultaneous pancreas‐kidney transplantation in the new millennium: Single‐center experience and review of the literature

R. Stratta, J. Rogers, G. Orlando, 2021, Clinical transplantation.

Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients

D. Segev, D. Warren, A. Massie, 2022, medRxiv.

A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response

J. Blankson, S. Klein, D. Segev, 2022, Transplantation.

Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

D. Segev, A. Massie, A. Tobian, 2021, Transplantation.

Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination

D. Segev, L. Christopher‐Stine, J. Paik, 2021, The Lancet Rheumatology.

Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series

J. Albayda, D. Segev, L. Christopher‐Stine, 2021, Annals of the Rheumatic Diseases.

Novel approach to recurrent cavoatrial renal cell carcinoma.

J. Black, M. Allaf, A. Shah, 2012, The Annals of thoracic surgery.

Higher Mortality in registrants with sudden model for end‐stage liver disease increase: Disadvantaged by the current allocation policy

D. Segev, A. Massie, Xun Luo, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipients

D. Segev, R. Ghobrial, A. Tobian, 2022, American Journal of Transplantation.

Surgical Management of Encapsulating Peritoneal Sclerosis: A Case Report in Kidney Transplant Patient

K. Brayman, A. Agarwal, F. Azari, 2018, Case reports in surgery.

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients

J. Blankson, S. Klein, D. Segev, 2021, American Journal of Transplantation.

Patterns of primary care utilization before and after living kidney donation

Tanjala S. Purnell, D. Segev, A. Massie, 2017, Clinical transplantation.

After Kidney Donation CKD , Chronic Kidney Disease ESRD , End Stage Renal Disease LKD , Live Kidney Donation PCP , Primary Care Provider

D. Segev, A. Massie, Xun Luo, 2017 .

Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients

D. Segev, A. Massie, J. Alejo, 2022, JAMA network open.

Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS‐CoV‐2 vaccines in solid organ transplant recipients: A case series

D. Segev, D. Warren, A. Massie, 2022, Clinical transplantation.

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination

D. Segev, D. Warren, A. Massie, 2022, American Journal of Transplantation.

Perivaccination Antimetabolite Hold and Third Dose of SARS-CoV-2 Vaccine in Lung Transplant Recipients: Preliminary Report.

P. Shah, D. Segev, R. Avery, 2022, Transplantation.

Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients.

D. Segev, D. Warren, A. Massie, 2022, Transplantation.

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

D. Segev, D. Warren, A. Massie, 2023, American Journal of Transplantation.

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease

Ami A. Shah, J. Albayda, D. Segev, 2022, Rheumatology.

Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipients

D. Segev, D. Warren, A. Massie, 2022, Clinical transplantation.

Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave.

D. Segev, D. Warren, A. Massie, 2022, Transplantation.

Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update

D. Segev, D. Warren, A. Massie, 2022, Transplantation.

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients

J. Blankson, S. Klein, D. Segev, 2021, American Journal of Transplantation.

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease

D. Segev, A. Massie, L. Christopher‐Stine, 2022, The Lancet Rheumatology.

A case of rhabdomyolysis after kidney transplantation successfully managed with intensive continuous dialysis

K. Brayman, A. Doyle, A. Agarwal, 2018, Journal of surgical case reports.

Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases

D. Segev, A. Massie, L. Christopher‐Stine, 2021, Annals of the Rheumatic Diseases.

Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series

Ami A. Shah, D. Segev, A. Massie, 2021, Annals of the Rheumatic Diseases.

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

D. Segev, D. Warren, A. Massie, 2023, American Journal of Transplantation.

Six-month Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients

D. Segev, D. Warren, A. Massie, 2021, Transplantation.

Incidence of SARS‐CoV‐2 infection among unvaccinated US adults during the Omicron wave

M. Makary, D. Segev, A. Massie, 2022, medRxiv.

Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipients

J. Blankson, D. Segev, N. Rouphael, 2023, JCI insight.

Patient‐reported outcomes after Tixagevimab and Cilgavimab pre‐exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk

D. Segev, A. Massie, A. Tobian, 2023, Clinical transplantation.

Erratum: Survival benefit of primary deceased donor transplantation with high-KDPI kidneys (American Journal of Transplantation (2014) 14 (2310-2316) DOI: 10.1111/ajt.12830)

D. Segev, E. Chow, A. Massie, 2015 .

Laparoscopic Versus Finger-Assisted Open Donor Nephrectomy Technique: A Possible Safe Alternative.

G. Saracino, D. Maluf, F. Azari, 2020, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients

D. Segev, D. Warren, A. Massie, 2022, Transplantation.

Improved humoral immunogenicity with mRNA‐1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses

D. Segev, D. Warren, A. Massie, 2022, Clinical transplantation.

Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients

J. Blankson, D. Segev, Y. Eby, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept.

J. Blankson, D. Segev, D. Warren, 2022, Transplantation.

210.5: Differential Immunogenicity of mRNA-1273 Versus BNT162b2 as a Third Vaccine Dose for Solid Organ Transplant Recipients Seronegative After Two BNT162b2 Doses.

D. Segev, D. Warren, A. Massie, 2022, Transplantation.

Survival Benefit of Primary Deceased Donor Transplantation With High‐KDPI Kidneys

D. Segev, E. Chow, A. Massie, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.